We are live on ! Find out more
JIC

Johnson Investment Counsel Portfolio holdings

AUM $13.7B
1-Year Est. Return 21.52%
This Fund
S&P 500
This Quarter Est. Return
+18.67%
1 Year Est. Return
+21.52%
3 Year Est. Return
+66.26%
5 Year Est. Return
+83.65%
10 Year Est. Return
+316.44%
AUM
$4.95B
AUM Growth
+$426M
Cap. Flow
-$213M
Cap. Flow %
-4.31%
Top 10 Hldgs %
33%
Holding
606
New
82
Increased
120
Reduced
313
Closed
29

Top Sells

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$82.2M
2
ZBH icon
Zimmer Biomet
ZBH
+$47.9M
3
MDT icon
Medtronic
MDT
+$46M
4
ACN icon
Accenture
ACN
+$41.2M
5
XYL icon
Xylem
XYL
+$37.2M

Sector Composition

Rank Sector Weight
1 Technology 14.86%
2 Financials 13.47%
3 Healthcare 11.85%
4 Consumer Staples 9.89%
5 Industrials 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
226
Applied Materials
AMAT
$415B
$1.28M 0.03%
21,232
-621
-3% -$33.5K
TSM icon
227
TSMC
TSM
$2.17T
$1.28M 0.03%
22,371
+606
+3% +$31.9K
XLF icon
228
State Street Financial Select Sector SPDR ETF
XLF
$59B
$1.26M 0.03%
54,577
-1,891
-3% -$42.9K
IEX icon
229
IDEX
IEX
$17.2B
$1.26M 0.03%
7,970
-665
-8% -$102K
STAG icon
230
STAG Industrial
STAG
$7.09B
$1.25M 0.03%
42,634
-186
-0.4% -$4.9K
AMP icon
231
Ameriprise Financial
AMP
$49.2B
$1.25M 0.03%
+8,358
New +$1.07M
IT icon
232
Gartner
IT
$12.2B
$1.24M 0.03%
+10,251
New +$1.18M
IEMG icon
233
iShares Core MSCI Emerging Markets ETF
IEMG
$155B
$1.23M 0.02%
25,806
-4,478
-15% -$200K
TMO icon
234
Thermo Fisher Scientific
TMO
$222B
$1.23M 0.02%
3,386
-190
-5% -$63.7K
BLK icon
235
Blackrock
BLK
$175B
$1.22M 0.02%
2,247
-82
-4% -$41.4K
CHD icon
236
Church & Dwight Co
CHD
$24.5B
$1.22M 0.02%
15,823
-270
-2% -$19.6K
PCTY icon
237
Paylocity
PCTY
$7.73B
$1.22M 0.02%
8,380
-160
-2% -$18.6K
UHS icon
238
Universal Health Services
UHS
$10.5B
$1.22M 0.02%
13,100
+1,970
+18% +$197K
SON icon
239
Sonoco
SON
$5.72B
$1.22M 0.02%
+23,250
New +$1.15M
IBB icon
240
iShares Biotechnology ETF
IBB
$9.82B
$1.21M 0.02%
8,872
-52
-0.6% -$6.63K
COP icon
241
ConocoPhillips
COP
$148B
$1.21M 0.02%
28,762
-2,069
-7% -$83.7K
NVS icon
242
Novartis
NVS
$298B
$1.2M 0.02%
13,774
-143
-1% -$12.3K
GRC icon
243
Gorman-Rupp
GRC
$2.16B
$1.2M 0.02%
38,507
+8,113
+27% +$238K
RP
244
DELISTED
RealPage, Inc.
RP
$1.19M 0.02%
18,315
+314
+2% +$19.8K
UBS icon
245
UBS Group
UBS
$177B
$1.19M 0.02%
102,925
-136,855
-57% -$1.41M
RRX icon
246
Regal Rexnord
RRX
$11.5B
$1.18M 0.02%
13,480
HUM icon
247
Humana
HUM
$46.3B
$1.17M 0.02%
3,014
+300
+11% +$112K
PTC icon
248
PTC
PTC
$16.4B
$1.17M 0.02%
15,052
+220
+1% +$15.6K
EPAY
249
DELISTED
Bottomline Technologies Inc
EPAY
$1.17M 0.02%
+23,070
New +$1.03M
IPGP icon
250
IPG Photonics
IPGP
$3.61B
$1.16M 0.02%
7,237
-275
-4% -$39.2K

Similar funds

Johnson Investment Counsel's Q2 2020 Portfolio in Review

As of Q2 2020, Johnson Investment Counsel held 606 positions worth $4.95B, up 9.4% from $4.52B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Johnson Investment Counsel withdrew a net $213M in Q2 2020, closing 29 positions and reducing 313 holdings. Its most notable exit was MutualFirst Financial Inc, an estimated $4.93M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Johnson Investment Counsel opened a new position in Alphabet (Google) Class A worth $90.7M.

  • Johnson Investment Counsel's largest Q2 2020 buy was Alphabet (Google) Class A: 1,278,860 shares worth $90.7M.
  • Johnson Investment Counsel added most to Nasdaq in Q2 2020, an estimated $13.2M increase.
  • Johnson Investment Counsel's biggest Q2 2020 reduction was Zoetis, cutting an estimated $82.2M.
  • Johnson Investment Counsel fully exited MutualFirst Financial Inc in Q2 2020, selling an estimated $4.93M.
  • Johnson Investment Counsel's ten largest holdings make up 33% of its $4.95B portfolio in Q2 2020.
  • Johnson Investment Counsel opened 82 new positions and closed 29 in Q2 2020.
  • Johnson Investment Counsel's portfolio value rose 9.4% quarter-over-quarter to $4.95B.

Based on Johnson Investment Counsel's 13F filing for Q2 2020, filed 13 Aug 2020.